⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1029111 | 0.57 | — | — | |
| SCHEMBL1617434 | 0.54 | — | — | |
| SCHEMBL182121 | 0.53 | — | — | |
| SCHEMBL4362773 | 0.50 | — | — | |
| SCHEMBL11809662 | 0.43 | — | — | |
| SCHEMBL129122 | 0.42 | — | — | |
| SCHEMBL329489 | 0.39 | — | — | |
| SCHEMBL317417 | 0.39 | — | — | |
| SCHEMBL5074226 | 0.39 | — | — | |
| SCHEMBL3275937 | 0.36 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2453 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4399215-A1 | IMPROVED METHODS FOR PRODUCTION OF CYCLIC GUANOSINE-MONOPHOSPHATE ANALOGUES | Mireca Medicines GmbH (DE) | 2024-07-17 | — | — | EP | claimed |
| EP-4389130-A1 | APPLICATION OF STEROID COMPOUND IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING EYE FLOATERS | Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. (CN) | 2024-06-26 | — | — | EP | claimed |
| US-11873309-B2 | Heterocyclic compounds as immunomodulators | INCYTE CORPORATION (US) | 2024-01-16 | — | — | US | claimed |
| US-11718605-B2 | Heterocyclic compounds as immunomodulators | INCYTE CORPORATION (US) | 2023-08-08 | — | — | US | claimed |
| EP-3687529-B1 | POTENT ANTIVIRAL PYRIDINE-CONTAINING COMPOUNDS | UNIV CALIFORNIA (US) | 2023-07-12 | — | — | EP | claimed |
| EP-4204401-A1 | COMPOUNDS FOR AND METHODS OF TREATING DISEASES | Alterity Therapeutics Limited (AU) | 2023-07-05 | — | — | EP | claimed |
| CN-116323558-A | Compounds and methods for treating diseases | 艾特里提治疗有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-115846586-A | Curing agent for casting and preparation method thereof | 江苏华岗材料科技发展有限公司 | 2023-03-28 | — | — | CN | claimed |
| US-11608337-B2 | Heterocyclic compounds as immunomodulators | INCYTE CORPORATION (US) | 2023-03-21 | — | — | US | claimed |
| US-11603364-B2 | Acyl hydrazone derivative compounds for treating disease | Alterity Therapeutics Limited (AU) | 2023-03-14 | — | — | US | claimed |
| WO-1992003451-A1 | BISPHOSPHONIC ACID DERIVATIVES AS ANTI-ARTHRITIC AGENTS | THE UPJOHN COMPANY (US) | 1992-03-05 | — | — | WO | claimed |
| WO-1991011435-A2 | NEW CENTRALLY ACTING 6,7,8,9-TETRAHYDRO-3H-BENZ(e)INDOLE HETEROCYCLICS | THE UPJOHN COMPANY (US) | 1991-08-08 | — | — | WO | claimed |
| EP-0283217-B1 | NOVEL ANTIHYPERCHOLESTEROLEMIC COMPOUNDS | MERCK & CO. INC. (US) | 1990-12-12 | — | — | EP | claimed |
| EP-0375393-A1 | Avermectin derivatives | MERCK & CO. INC. (US) | 1990-06-27 | — | — | EP | claimed |
| US-4902709-A | ANTILIPEMIC AGENTS | MERCK & CO., INC. (US) | 1990-02-20 | — | — | US | claimed |
| EP-0343307-A1 | 4-Piperidinealkanamine derivatives | FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A. (ES) | 1989-11-29 | — | — | EP | claimed |
| EP-0126311-B1 | BENZOPYRAN DERIVATIVES. | BEECHAM GROUP PLC (GB) | 1989-09-13 | — | — | EP | claimed |
| EP-0283217-A1 | Novel antihypercholesterolemic compounds | MERCK & CO. INC. (US) | 1988-09-21 | — | — | EP | claimed |
| US-4571406-A | Anti-hypertensive chromans and chromenes | BEECHAM GROUP P.L.C. (GB) | 1986-02-18 | — | — | US | claimed |
| EP-0126311-A2 | Benzopyran derivatives. | BEECHAM GROUP PLC (GB) | 1984-11-28 | — | — | EP | claimed |